1. Home
  2. CMMB vs FGL Comparison

CMMB vs FGL Comparison

Compare CMMB & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMMB
  • FGL
  • Stock Information
  • Founded
  • CMMB 2004
  • FGL 2021
  • Country
  • CMMB Israel
  • FGL Malaysia
  • Employees
  • CMMB N/A
  • FGL N/A
  • Industry
  • CMMB Biotechnology: Pharmaceutical Preparations
  • FGL
  • Sector
  • CMMB Health Care
  • FGL
  • Exchange
  • CMMB Nasdaq
  • FGL NYSE
  • Market Cap
  • CMMB 23.0M
  • FGL 25.4M
  • IPO Year
  • CMMB N/A
  • FGL 2024
  • Fundamental
  • Price
  • CMMB $1.32
  • FGL $1.08
  • Analyst Decision
  • CMMB Strong Buy
  • FGL
  • Analyst Count
  • CMMB 2
  • FGL 0
  • Target Price
  • CMMB $8.50
  • FGL N/A
  • AVG Volume (30 Days)
  • CMMB 109.4K
  • FGL 51.9K
  • Earning Date
  • CMMB 05-15-2025
  • FGL 06-21-2025
  • Dividend Yield
  • CMMB N/A
  • FGL N/A
  • EPS Growth
  • CMMB N/A
  • FGL N/A
  • EPS
  • CMMB N/A
  • FGL N/A
  • Revenue
  • CMMB N/A
  • FGL $20,205,441.00
  • Revenue This Year
  • CMMB N/A
  • FGL N/A
  • Revenue Next Year
  • CMMB N/A
  • FGL N/A
  • P/E Ratio
  • CMMB N/A
  • FGL N/A
  • Revenue Growth
  • CMMB N/A
  • FGL N/A
  • 52 Week Low
  • CMMB $0.78
  • FGL $0.70
  • 52 Week High
  • CMMB $2.55
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • CMMB 50.69
  • FGL N/A
  • Support Level
  • CMMB $1.31
  • FGL N/A
  • Resistance Level
  • CMMB $1.44
  • FGL N/A
  • Average True Range (ATR)
  • CMMB 0.08
  • FGL 0.00
  • MACD
  • CMMB 0.00
  • FGL 0.00
  • Stochastic Oscillator
  • CMMB 54.55
  • FGL 0.00

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.

About FGL FOUNDER GROUP LTD

Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.

Share on Social Networks: